1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient characteristics and clinical data (n = 14)
Age of diagnosis, y Median 9.7 Range 1.8–18 Sex Male 7 (50%) Female 7 (50%) MRI findings NF-1 spots 14 (100%) Optic nerve/chiasm thickening 7 (50%) Plexiform neurofibroma 6 (43%) Clinical findings Headaches 6 (43%) Cognitive or speech delay 5 (36%) ADHD 2 (14%)
Note:—ADHD indicates attention deficit/hyperactivity disorder.